RPB-supported researchers at the University of Southern California Roski Eye Institute conducted the human trial.
RPB-supported researchers made a critical discovery about the gene mutation that causes many retinal degenerative diseases, opening the door for a new line of research into potential treatments.
New RPB-supported research provides hope for transplants of neural stem cells as future treatment for brain injuries.
A new approach to removing congenital cataracts in infants allows remaining stem cells to regrow functional lenses.
At the ARVO Inaugural Press Conference, three RPB-funded scientists pushing the boundaries of imaging, early detection, regeneration.